Ibuprofen, other NSAIDs and COVID-19: a narrative review

At the start of the coronavirus disease 2019 (COVID-19) pandemic (March 2020), there was speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, used to manage some of the symptoms of COVID-19, could increase the susceptibility to severe acute respiratory syndrome coronavi...

Descripción completa

Detalles Bibliográficos
Autores principales: Laughey, William, Lodhi, Imran, Pennick, Graham, Smart, Lucinda, Sanni, Olutoba, Sandhu, Suneet, Charlesworth, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518289/
https://www.ncbi.nlm.nih.gov/pubmed/37603158
http://dx.doi.org/10.1007/s10787-023-01309-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518289/
https://www.ncbi.nlm.nih.gov/pubmed/37603158
http://dx.doi.org/10.1007/s10787-023-01309-7

Ejemplares similares